| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| D4PHA4 | GC-rich promoter binding protein 1, isoform CRA_c; Vasculin; | GPBP1; | XP_005248630.1;XP_006714737.1; | 493 | human |
| Q7Z3M5 | HCG1733973, isoform CRA_a; Putative uncharacterized protein DKFZp686E10196; | DKFZp686E10196; | NULL | 147 | human |
| A0A024RCZ1 | LEM domain containing 2, isoform CRA_a; | LEMD2; | NULL | 503 | human |
| C9JIR1 | Melanoma-associated antigen 4; Fragment; | MAGEA4; | NULL | 241 | human |
| A0A024QYX8 | Wiskott-Aldrich syndrome (Eczema-thrombocytopenia), isoform CRA_a; | WAS; | NULL | 502 | human |
| K7ERE1 | Uncharacterized protein; | NULL | NULL | 68 | human |
| F1CIE7 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| H9NTE5 | ATP synthase subunit a; | ATP6; | NULL | 226 | human |
| Q5T249 | 3-keto-steroid reductase; HCG2024989, isoform CRA_g; | HSD17B7; | NULL | 84 | human |
| F2Z322 | Putative RNA-binding protein Luc7-like 1; | LUC7L; | NULL | 55 | human |
| U3M4F0 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| F5H4X8 | FXYD domain-containing ion transport regulator 5; | FXYD5; | XP_006723308.1;XP_006723309.1; | 194 | human |
| B1W974 | NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3; | NADH4L; ND4L; | NULL | 98 | human |
| Q9UHK3 | Chromosome 5 open reading frame 4, isoform CRA_a; Putative tumor suppressor; | C5orf4; | NULL | 144 | human |
| Q4F1M8 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; | NULL | 513 | human |
| J7H7C4 | NANOGP8; Fragment; | NANOGP8; | NULL | 130 | human |
| Q85KW5 | ATP synthase protein 8; | ATP8; | NULL | 68 | human |
| Q5XT74 | Cytochrome c oxidase subunit 1; EC 1.9.3.1; | COX1; COI coxI; | NULL | 513 | human |
| D6RBC3 | THAP domain containing 6, isoform CRA_e; THAP domain-containing protein 6; | THAP6; | NULL | 119 | human |
| Q969P4 | Chromosome 17 open reading frame 62, isoform CRA_d; cDNA FLJ14837 fis, clone OVARC1001711, weakly similar to CORNIFIN B; cDNA FLJ31780 fis, clone NT2RI2008221, weakly similar to CORNIFIN B; | C17orf62; | NULL | 223 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |